TTN (Titin) variants and mutations
TTN (also known as Titin) is a human protein-coding gene encoding a titin protein. Its enormous titin polypeptide spans much of the sarcomere and provides passive elasticity, structural alignment, and mechanosensing in striated muscle. Truncating variants are among the most common genetic causes of dilated cardiomyopathy, while other variants cause diverse skeletal and cardiac myopathies. This analysis covers 51,979 TTN variants and mutations. Of these, 26% have computational variant effect predictions. Disease context includes dilated cardiomyopathy, dilated cardiomyopathy 1G, and cardiomyopathy. Example TTN variants include T2P, T3N, and T3P.
Variant analysis overview
- Gene: TTN
- Protein: Titin
- UniProt accession: Q8WZ42
- Organism: Homo sapiens
- Variants analyzed: 51979
- Variant scope: all variants
- Completed: 2026-08-10
Variant and mutation evidence
- Variant composition: 51,975 unspecified-consequence records; 1 stop retained variant; 1 stop lost; 2 substitution
- Prediction scores: 13,671 variants have prediction scores (26% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: dilated cardiomyopathy, dilated cardiomyopathy 1G, cardiomyopathy, tibial muscular dystrophy, early-onset myopathy with fatal cardiomyopathy, myopathy, myofibrillar, 9, with early respiratory failure, autosomal recessive limb-girdle muscular dystrophy type 2J, hypertrophic cardiomyopathy 9, atrial fibrillation, heart failure, Hereditary proximal myopathy with early respiratory failure, Rare familial disorder with hypertrophic cardiomyopathy.
Protein structure and variant hotspots
- Protein features: 285 domains; 2 binding sites; 15 post-translational modification sites.
- Structural context: 39,825 variants have structural context.
- PTM context: 22 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable TTN variants
Examples include T2P, T3N, T3P, Q4*, Q4P, A5G, A5H, A5T. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- T2P (p.Thr2Pro), TOPMed rs2094228974, CADD 17.80, PolyPhen-2 0.05
- T3N (p.Thr3Asn), TOPMed rs2094228790, CADD 23.30, PolyPhen-2 0.29
- T3P (p.Thr3Pro), Ensembl rs1575037903
- Q4* (p.Gln4Ter), rs2534633050, ClinGen CA349534004, ClinVar RCV002735354, Likely pathogenic
- Q4P (p.Gln4Pro), gnomAD rs1203552331, CADD 23.40, PolyPhen-2 0.17
- A5G (p.Ala5Gly), gnomAD rs1276621014
- A5H (p.Ala5His), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- A5T (p.Ala5Thr), rs552620474, ClinGen CA2006457, ClinVar RCV000604870, ClinVar RCV001485555, CADD 25.70, PolyPhen-2 1.00, Likely benign
- P6L (p.Pro6Leu), rs201490999, ClinGen CA179456, ClinVar RCV000152540, ClinVar RCV000765597, CADD 28.10, PolyPhen-2 1.00, Uncertain significance
- T7A (p.Thr7Ala), ExAC rs752073551, gnomAD rs752073551, CADD 23.10, PolyPhen-2 0.04
- T7K (p.Thr7Lys), ExAC rs761344572, TOPMed rs761344572, gnomAD rs761344572, CADD 23.40, PolyPhen-2 0.40, Uncertain significance
- T7M (p.Thr7Met), rs761344572, ClinGen CA2006452, NCI-TCGA Cosmic COSV6004, cosmic curated COSV60049, CADD 23.30, PolyPhen-2 0.06, Uncertain significance
- F8C (p.Phe8Cys), cosmic curated COSV60189, TOPMed rs1561542611
- T9K (p.Thr9Lys), rs146123323, ClinGen CA60990095, ClinVar RCV003137190, ESP rs146123323, CADD 17.30, Uncertain significance
- T9M (p.Thr9Met), rs146123323, ClinGen CA311439, cosmic curated COSV60177, ClinVar RCV000185182, CADD 17.40, PolyPhen-2 0.23, Uncertain significance
- T9P (p.Thr9Pro), TOPMed rs1298028827, gnomAD rs1298028827, Uncertain significance
- T9S (p.Thr9Ser), rs1298028827, ClinGen CA349533884, ClinVar RCV001508123, TOPMed rs1298028827, CADD 20.40, PolyPhen-2 0.00, Uncertain significance
- Q10* (p.Gln10Ter), gnomAD rs1309114959
- Q10P (p.Gln10Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P11L (p.Pro11Leu), rs768624416, ClinGen CA2006448, cosmic curated COSV59997, ClinVar RCV000642972, CADD 24.00, PolyPhen-2 0.33, Uncertain significance
- P11Q (p.Pro11Gln), NCI-TCGA Cosmic COSV5999, NCI-TCGA Cosmic COSV6038, cosmic curated COSV60382, Variant assessed as somatic; moderate impact.
- P11S (p.Pro11Ser), rs775206165, ClinGen CA2006449, ClinVar RCV003886674, ExAC rs775206165, CADD 26.00, PolyPhen-2 0.96, Uncertain significance
- L12S (p.Leu12Ser), cosmic curated COSV60011, CADD 26.40, PolyPhen-2 0.96
- S14I (p.Ser14Ile), rs771027745, ClinGen CA2006446, ClinVar RCV000217615, ClinVar RCV000726334, CADD 24.80, PolyPhen-2 1.00, Uncertain significance
- S14N (p.Ser14Asn), ExAC rs771027745, gnomAD rs771027745, CADD 24.20, PolyPhen-2 0.99, Uncertain significance
- V15A (p.Val15Ala), cosmic curated COSV10886, gnomAD rs1471462382, CADD 24.70, PolyPhen-2 0.90
- V15F (p.Val15Phe), rs201857541, ClinGen CA349533693, ClinVar RCV003143237, AlphaMissense 0.09, MetaLR 0.18, Uncertain significance
- V15I (p.Val15Ile), rs201857541, ClinGen CA238531, NCI-TCGA Cosmic COSV6042, cosmic curated COSV60420, AlphaMissense 0.09, MetaLR 0.18, Benign
- V16M (p.Val16Met), rs756212082, ClinGen CA2006444, cosmic curated COSV10741, ClinVar RCV001799206, CADD 25.30, PolyPhen-2 1.00, Uncertain significance
- L18R (p.Leu18Arg), ExAC rs748322000, TOPMed rs748322000, gnomAD rs748322000, CADD 29.30, PolyPhen-2 1.00, Uncertain significance, not provided
- E19A (p.Glu19Ala), Ensembl rs954288080
- E19D (p.Glu19Asp), ExAC rs781416228, gnomAD rs781416228, CADD 24.70, PolyPhen-2 0.94
- E19G (p.Glu19Gly), Ensembl rs954288080, CADD 32.00, PolyPhen-2 1.00
- E19Q (p.Glu19Gln), Ensembl rs1002522376
- G20C (p.Gly20Cys), NCI-TCGA Cosmic COSV1005, NCI-TCGA Cosmic COSV1006, cosmic curated COSV10060, Variant assessed as somatic; moderate impact.
- G20S (p.Gly20Ser), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10059, NCI-TCGA Cosmic COSV1006, Variant assessed as somatic; moderate impact.
- S21T (p.Ser21Thr), gnomAD rs1211610408, CADD 24.40, PolyPhen-2 0.94
- T22A (p.Thr22Ala), rs1305775594, NCI-TCGA Cosmic COSV6023, cosmic curated COSV60234, gnomAD rs1305775594, CADD 16.40, PolyPhen-2 0.00, Variant assessed as somatic; moderate impact.
- T22N (p.Thr22Asn), Ensembl rs2154361000
- T22S (p.Thr22Ser), NCI-TCGA Cosmic COSV6023, Variant assessed as somatic; moderate impact.
- A23T (p.Ala23Thr), cosmic curated COSV60353, ESP rs147812158, ExAC rs147812158, TOPMed rs147812158, CADD 25.60, PolyPhen-2 1.00
- T24I (p.Thr24Ile), rs536235994, ClinGen CA60990017, ClinVar RCV001700845, ClinVar RCV002506733, CADD 25.90, PolyPhen-2 1.00, Uncertain significance
- T24N (p.Thr24Asn), rs536235994, ClinGen CA2006436, ClinVar RCV002370839, ClinVar RCV005635525, CADD 25.30, PolyPhen-2 0.99, Uncertain significance
- T24P (p.Thr24Pro), ExAC rs758953324, gnomAD rs758953324, CADD 25.20, PolyPhen-2 0.99
- T24S (p.Thr24Ser), rs536235994, ClinGen CA2006437, ClinVar RCV002370842, ClinVar RCV005405899, CADD 25.00, PolyPhen-2 0.96, Likely benign
- F25L (p.Phe25Leu), cosmic curated COSV10060
- A27V (p.Ala27Val), ExAC rs760167840, TOPMed rs760167840, gnomAD rs760167840, CADD 27.40, PolyPhen-2 1.00, Uncertain significance, not provided
- H28D (p.His28Asp), ExAC rs752309578, gnomAD rs752309578
- H28Y (p.His28Tyr), cosmic curated COSV60261, CADD 23.70, PolyPhen-2 0.34
- I29T (p.Ile29Thr), cosmic curated COSV60366
- I29V (p.Ile29Val), cosmic curated COSV10521, gnomAD rs1458992819, CADD 3.92, PolyPhen-2 0.00
- S30N (p.Ser30Asn), rs767153909, ClinGen CA2006433, ClinVar RCV000643007, ClinVar RCV003139979, CADD 26.80, PolyPhen-2 0.64, Uncertain significance
- P33Q (p.Pro33Gln), Ensembl rs878925929
- P33S (p.Pro33Ser), cosmic curated COSV10464
- V34F (p.Val34Phe), TOPMed rs1209644934, gnomAD rs1209644934, CADD 25.30, PolyPhen-2 0.88
- V34G (p.Val34Gly), cosmic curated COSV10464
- V34I (p.Val34Ile), TOPMed rs1209644934, gnomAD rs1209644934
- P35A (p.Pro35Ala), ExAC rs779420414, TOPMed rs779420414, gnomAD rs779420414, CADD 24.80, PolyPhen-2 0.99
- P35L (p.Pro35Leu), ExAC rs755605142, gnomAD rs755605142, CADD 27.90, PolyPhen-2 1.00
- P35S (p.Pro35Ser), cosmic curated COSV10521
- P35T (p.Pro35Thr), ExAC rs779420414, TOPMed rs779420414, gnomAD rs779420414, CADD 26.40, PolyPhen-2 1.00, Uncertain significance, not provided
- E36K (p.Glu36Lys), Ensembl rs2094110497, CADD 26.60, PolyPhen-2 0.99
- V37M (p.Val37Met), Ensembl rs878907352
- F40L (p.Phe40Leu), rs1554045595, ClinGen CA349531511, ClinVar RCV000553830, Ensembl rs1554045595, AlphaMissense 0.88, MetaLR 0.07, Uncertain significance
- D42G (p.Asp42Gly), TOPMed rs200838218, gnomAD rs200838218, CADD 29.80, PolyPhen-2 1.00
- D42N (p.Asp42Asn), cosmic curated COSV10741, ExAC rs759317260, gnomAD rs759317260, CADD 24.70, PolyPhen-2 1.00
- G43S (p.Gly43Ser), Ensembl rs1201664037
- G43V (p.Gly43Val), Ensembl rs2154359887
- Q44H (p.Gln44His), rs751250111, ClinGen CA349531394, ClinVar RCV003487120, Likely benign
- Q44K (p.Gln44Lys), cosmic curated COSV10441
- Q44L (p.Gln44Leu), rs867308852, ClinGen CA349531409, ClinVar RCV000852947, TOPMed rs867308852, CADD 25.20, PolyPhen-2 0.97, Likely benign
- Q44R (p.Gln44Arg), TOPMed rs867308852, gnomAD rs867308852, CADD 24.80, PolyPhen-2 0.98, Likely benign
- V45L (p.Val45Leu), rs142028110, ClinGen CA2006411, cosmic curated COSV99045, ClinVar RCV002226171, CADD 22.60, PolyPhen-2 0.01, Uncertain significance
- I46T (p.Ile46Thr), TOPMed rs1391679740
- S47A (p.Ser47Ala), NCI-TCGA Cosmic COSV5988, cosmic curated COSV59886, NCI-TCGA Cosmic COSV6002, Variant assessed as somatic; moderate impact.
- S47T (p.Ser47Thr), NCI-TCGA Cosmic COSV5988, NCI-TCGA Cosmic COSV6002, cosmic curated COSV60027, Variant assessed as somatic; moderate impact.
- T48I (p.Thr48Ile), TOPMed rs1295047971, gnomAD rs1295047971, CADD 23.70, PolyPhen-2 0.02
- T48S (p.Thr48Ser), TOPMed rs1295047971, gnomAD rs1295047971
- S49F (p.Ser49Phe), ESP rs368887734, ExAC rs368887734, TOPMed rs368887734, gnomAD rs368887734, CADD 27.50
- S49P (p.Ser49Pro), 1000Genomes rs531066665, ExAC rs531066665, TOPMed rs531066665, gnomAD rs531066665, CADD 23.60, PolyPhen-2 0.09
- S49Y (p.Ser49Tyr), ESP rs368887734, ExAC rs368887734, TOPMed rs368887734, gnomAD rs368887734, CADD 26.90, PolyPhen-2 0.45
- T50A (p.Thr50Ala), cosmic curated COSV10968
- T50P (p.Thr50Pro), rs1217255349, ClinGen CA349531275, ClinVar RCV004545497, gnomAD rs1217255349, CADD 23.20, PolyPhen-2 0.25, Uncertain significance
- L51R (p.Leu51Arg), rs868419744, ClinGen CA60989112, ClinVar RCV002402951, TOPMed rs868419744, CADD 25.60, PolyPhen-2 1.00, Likely benign
- L51V (p.Leu51Val), cosmic curated COSV60387, CADD 24.10, PolyPhen-2 0.99
- P52H (p.Pro52His), cosmic curated COSV10062
- P52R (p.Pro52Arg), ExAC rs761625399, TOPMed rs761625399, gnomAD rs761625399, CADD 25.20, PolyPhen-2 1.00
- P52S (p.Pro52Ser), cosmic curated COSV10521
- G53S (p.Gly53Ser), rs150902810, ClinGen CA2006404, cosmic curated COSV59947, ClinVar RCV000465013, CADD 25.60, PolyPhen-2 1.00, Uncertain significance
- V54A (p.Val54Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact., in CMD1G
- V54M (p.Val54Met), rs139517732, ClinGen CA256511, ClinVar RCV000013492, ClinVar RCV001213576, CADD 22.80, PolyPhen-2 0.10, Pathogenic, in CMD1G
- Q55H (p.Gln55His), Ensembl rs1561527314, CADD 24.70, PolyPhen-2 0.93, Likely benign
- I56L (p.Ile56Leu), TOPMed rs2094107740, gnomAD rs2094107740, CADD 23.30
- I56V (p.Ile56Val), TOPMed rs2094107740, gnomAD rs2094107740
- S57F (p.Ser57Phe), rs1274297049, ClinGen CA349531079, cosmic curated COSV60346, ClinVar RCV001774705, CADD 25.60, PolyPhen-2 1.00, Uncertain significance
- S59R (p.Ser59Arg), rs191057824, ClinGen CA138956, ClinVar RCV000039956, ClinVar RCV000617724, CADD 24.20, PolyPhen-2 1.00, Benign
- D60N (p.Asp60Asn), 1000Genomes rs35683768, ESP rs35683768, ExAC rs35683768, TOPMed rs35683768, CADD 23.00, PolyPhen-2 0.11, Uncertain significance, Autosomal recessive limb-girdle muscular dystrophy type 2J; Hypertrophic cardiom
- D60V (p.Asp60Val), ExAC rs754533155, gnomAD rs754533155, CADD 24.60, PolyPhen-2 0.46
- D60Y (p.Asp60Tyr), rs35683768, ClinGen CA282808, ClinVar RCV000039957, ClinVar RCV000251100, CADD 24.60, PolyPhen-2 0.88, Benign
- R62C (p.Arg62Cys), rs766108359, ClinGen CA2006398, cosmic curated COSV59957, ClinVar RCV000400504, CADD 27.90, PolyPhen-2 1.00, Uncertain significance
- R62H (p.Arg62His), rs758169489, ClinGen CA2006397, NCI-TCGA Cosmic COSV1006, cosmic curated COSV10061, CADD 25.20, PolyPhen-2 1.00, Benign
- R62S (p.Arg62Ser), cosmic curated COSV99045
- A63G (p.Ala63Gly), ExAC rs761823259, gnomAD rs761823259
- A63P (p.Ala63Pro), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10058, NCI-TCGA Cosmic COSV6021, Variant assessed as somatic; moderate impact.
- A63T (p.Ala63Thr), rs764892312, ClinGen CA311611, NCI-TCGA Cosmic COSV1005, NCI-TCGA Cosmic COSV6021, CADD 24.50, PolyPhen-2 1.00, Uncertain significance
- A63V (p.Ala63Val), ExAC rs761823259, gnomAD rs761823259
- K64E (p.Lys64Glu), Ensembl rs2094106251
- T66A (p.Thr66Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T66M (p.Thr66Met), rs372755739, ClinGen CA2006395, cosmic curated COSV60099, ClinVar RCV000613481, CADD 1.77, PolyPhen-2 0.00, Likely benign
- I67F (p.Ile67Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- I67M (p.Ile67Met), NCI-TCGA Cosmic COSV5988, cosmic curated COSV59881, Variant assessed as somatic; moderate impact.
- I67N (p.Ile67Asn), rs952685437, NCI-TCGA Cosmic COSV6036, cosmic curated COSV60368, TOPMed rs952685437, CADD 25.60, Uncertain significance
- I67T (p.Ile67Thr), rs952685437, ClinGen CA349530881, ClinVar RCV000769147, TOPMed rs952685437, CADD 25.00, PolyPhen-2 1.00, Uncertain significance
- P68A (p.Pro68Ala), gnomAD rs876658046, Uncertain significance
- P68S (p.Pro68Ser), rs876658046, ClinGen CA10576583, cosmic curated COSV10741, ClinVar RCV000218944, CADD 21.40, PolyPhen-2 0.00, Uncertain significance
- A69S (p.Ala69Ser), cosmic curated COSV59885
- A69T (p.Ala69Thr), rs1370693255, ClinGen CA349530855, NCI-TCGA Cosmic COSV5988, NCI-TCGA Cosmic COSV5999, CADD 22.50, PolyPhen-2 0.02, Uncertain significance
- A69V (p.Ala69Val), NCI-TCGA Cosmic COSV5991, cosmic curated COSV59918, Ensembl rs2094105458, Variant assessed as somatic; moderate impact.
- V70L (p.Val70Leu), cosmic curated COSV60419
- V70M (p.Val70Met), rs772248060, ClinGen CA2006391, NCI-TCGA Cosmic COSV6022, cosmic curated COSV60229, CADD 24.40, PolyPhen-2 0.96, Likely benign
- T71F (p.Thr71Phe), cosmic curated COSV10817
- K72E (p.Lys72Glu), NCI-TCGA TCGA novel, CADD 22.70, PolyPhen-2 0.00, Variant assessed as somatic; moderate impact.
- K72T (p.Lys72Thr), gnomAD rs1200039660
- A73D (p.Ala73Asp), cosmic curated COSV60159, Ensembl rs2154359834
- N74D (p.Asn74Asp), TOPMed rs1247502317
- N74K (p.Asn74Lys), NCI-TCGA TCGA novel, Ensembl rs2094104209, CADD 22.40, PolyPhen-2 0.42, Variant assessed as somatic; moderate impact.
- N74S (p.Asn74Ser), ExAC rs774795341, gnomAD rs774795341, CADD 22.60, PolyPhen-2 0.12
- G76A (p.Gly76Ala), rs138750421, ClinGen CA2006387, ClinVar RCV000325596, ClinVar RCV000621535, CADD 24.60, PolyPhen-2 1.00, Benign
- G76R (p.Gly76Arg), ExAC rs771137064, gnomAD rs771137064, CADD 25.40, PolyPhen-2 1.00
- G76V (p.Gly76Val), ESP rs138750421, ExAC rs138750421, TOPMed rs138750421, gnomAD rs138750421, CADD 25.00, PolyPhen-2 1.00, Benign
- R77* (p.Arg77Ter), rs1347415564, ClinGen CA349530672, NCI-TCGA Cosmic COSV6038, cosmic curated COSV60385, CADD 37.00, Likely pathogenic
- R77Q (p.Arg77Gln), rs727503709, ClinGen CA179450, NCI-TCGA Cosmic COSV5986, cosmic curated COSV59864, CADD 23.20, PolyPhen-2 0.37, Uncertain significance
- Y78C (p.Tyr78Cys), NCI-TCGA Cosmic COSV6039, cosmic curated COSV60399, Variant assessed as somatic; moderate impact.
- S79F (p.Ser79Phe), NCI-TCGA Cosmic COSV5988, cosmic curated COSV59889, CADD 25.80, PolyPhen-2 0.94, Variant assessed as somatic; moderate impact.
- S79T (p.Ser79Thr), ExAC rs746487470, gnomAD rs746487470, CADD 22.80, PolyPhen-2 0.01
- L80Q (p.Leu80Gln), cosmic curated COSV10521
- K81T (p.Lys81Thr), cosmic curated COSV60046
- A82D (p.Ala82Asp), cosmic curated COSV10464
- A82P (p.Ala82Pro), Ensembl rs1575010544
- A82T (p.Ala82Thr), Ensembl rs1575010544, CADD 24.90, PolyPhen-2 1.00
- T83P (p.Thr83Pro), Ensembl rs1575010482
- N84D (p.Asn84Asp), gnomAD rs1349693054, CADD 25.20, PolyPhen-2 0.99
- N84K (p.Asn84Lys), ESP rs142851233, ExAC rs142851233, TOPMed rs142851233, gnomAD rs142851233, CADD 23.80
- N84S (p.Asn84Ser), rs912344670, ClinGen CA60989007, ClinVar RCV003137218, TOPMed rs912344670, CADD 24.40, PolyPhen-2 0.98, Uncertain significance
- G85E (p.Gly85Glu), cosmic curated COSV60022, ExAC rs758092470, gnomAD rs758092470, CADD 24.50, PolyPhen-2 1.00
- G85R (p.Gly85Arg), cosmic curated COSV10464
- S86C (p.Ser86Cys), cosmic curated COSV60219
- S86F (p.Ser86Phe), cosmic curated COSV10464, CADD 26.20, PolyPhen-2 0.94
- S86Y (p.Ser86Tyr), ExAC rs749985986, TOPMed rs749985986, gnomAD rs749985986, CADD 25.60, PolyPhen-2 0.96
- G87R (p.Gly87Arg), rs756996890, ExAC rs756996890, TOPMed rs756996890, gnomAD rs756996890, CADD 24.80, PolyPhen-2 1.00, Uncertain significance
- G87V (p.Gly87Val), cosmic curated COSV60025, CADD 24.50, PolyPhen-2 1.00
- A89G (p.Ala89Gly), rs200165636, ClinGen CA302585, ClinVar RCV000172495, ClinVar RCV000524658, CADD 25.60, PolyPhen-2 0.99, Benign
- A89T (p.Ala89Thr), Ensembl rs1259283214, CADD 24.60, PolyPhen-2 1.00
- A89V (p.Ala89Val), cosmic curated COSV60314, ESP rs200165636, ExAC rs200165636, TOPMed rs200165636, CADD 25.60, PolyPhen-2 0.99, Benign
- T90I (p.Thr90Ile), cosmic curated COSV10058
- S91I (p.Ser91Ile), rs1367815458, TOPMed rs1367815458, gnomAD rs1367815458, CADD 24.30, Variant assessed as somatic; moderate impact.
- T92A (p.Thr92Ala), ExAC rs767442718, gnomAD rs767442718, CADD 24.60, PolyPhen-2 0.99
- T92S (p.Thr92Ser), ExAC rs767442718, gnomAD rs767442718, CADD 24.10, PolyPhen-2 0.99
- A93G (p.Ala93Gly), rs1473207810, ClinGen CA349530217, ClinVar RCV000531038, ClinVar RCV000593365, AlphaMissense 0.34, MetaLR 0.51, Uncertain significance
- A93S (p.Ala93Ser), NCI-TCGA TCGA novel, CADD 24.50, PolyPhen-2 0.99, Variant assessed as somatic; moderate impact.
- A93T (p.Ala93Thr), Ensembl rs1575009860, CADD 25.20, PolyPhen-2 1.00
- A93V (p.Ala93Val), gnomAD rs1473207810, AlphaMissense 0.34, MetaLR 0.51, Uncertain significance
- E94Q (p.Glu94Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L95F (p.Leu95Phe), rs774434865, NCI-TCGA Cosmic COSV1005, cosmic curated COSV10059, ExAC rs774434865, CADD 24.90, PolyPhen-2 1.00, Variant assessed as somatic; moderate impact.
- L95R (p.Leu95Arg), cosmic curated COSV60022
- V97M (p.Val97Met), rs185921345, ClinGen CA182016, cosmic curated COSV59907, ClinVar RCV000155019, CADD 24.30, PolyPhen-2 0.95, Benign
- K98N (p.Lys98Asn), cosmic curated COSV60286
- K98R (p.Lys98Arg), NCI-TCGA Cosmic COSV6039, cosmic curated COSV60398, Variant assessed as somatic; moderate impact.
- A99G (p.Ala99Gly), TOPMed rs1386336843, gnomAD rs1386336843
- A99S (p.Ala99Ser), cosmic curated COSV10817
- A99T (p.Ala99Thr), TOPMed rs2094100516
- A99V (p.Ala99Val), TOPMed rs1386336843, gnomAD rs1386336843, CADD 23.60, PolyPhen-2 0.14
- E100K (p.Glu100Lys), rs966391166, Ensembl rs966391166, AlphaMissense 0.35, MetaLR 0.24, Variant assessed as somatic; moderate impact.
- T101A (p.Thr101Ala), rs138945705, ClinGen CA2006343, cosmic curated COSV10059, ClinVar RCV003137268, CADD 22.30, PolyPhen-2 0.30, Uncertain significance
- T101I (p.Thr101Ile), rs879185669, ClinGen CA16610577, NCI-TCGA Cosmic COSV6039, cosmic curated COSV60391, CADD 22.60, PolyPhen-2 0.16, Uncertain significance
- A102T (p.Ala102Thr), Ensembl rs752812697, CADD 23.80, PolyPhen-2 0.99
- P103S (p.Pro103Ser), rs1392286336, NCI-TCGA Cosmic COSV5990, cosmic curated COSV59903, NCI-TCGA Cosmic COSV5992, AlphaMissense 0.26, MetaLR 0.55, Variant assessed as somatic; moderate impact.
- P103T (p.Pro103Thr), cosmic curated COSV59927
- P104S (p.Pro104Ser), ExAC rs752692701, gnomAD rs752692701, CADD 24.50, PolyPhen-2 1.00
- N105D (p.Asn105Asp), rs780972429, ClinVar RCV004560491, ExAC rs780972429, TOPMed rs780972429, AlphaMissense 0.20, MetaLR 0.36, Uncertain significance
Public TTN analysis runs
- TTN analysis run — TTN (51,979 variants) — completed 2026-08-10
- TTN analysis run — TTN (51,979 variants) — completed 2026-08-10